U.S. Textile Dyes Market to Reach USD 4.34 Billion and Europe USD 4.35 Billion by 2035, Driven by Eco-Friendly Dye Technologies and Regulatory Compliance
Bimergen Energy Emerges With $8.9 Million Revenue Transaction
With the Redbird project and two Texas 10s closed as of July 15, 2026, Bimergen has received $6.4 million cash and will receive an additional $2.5 million upon Redbird project milestones
ProMIS Neurosciences Reports Positive Blinded Six-Month Interim Safety and Biomarker Data for PMN310 in the PRECISE-AD Phase 1b Alzheimer’s Disease Trial
No ARIA-E observed across all genotypes, including APOE4 homozygotes
Micropep Advances Global Commercialization of Peptide Biofungicide with U.S. and EU Regulatory Filings
EUDA Health Signs Important Tri-Party Memorandum of Understanding with GO POSB Organoids and Shenzhen Inno to Significantly Advance Next-Generation iPSC and NK-TCR Cell Therapies
SINGAPORE, July 28, 2026 (GLOBE NEWSWIRE) — EUDA Health Holdings Limited (NASDAQ: EUDA) a Singapore-based distributor of third-party provided wellness and non-invasive healthcare products and services in Asia, with a focus on Singapore, Malaysia and China, today announced that it has signed a Memorandum of Understanding (“MOU”) with GO POSB Organoids Pte Ltd (“GO POSB”) and Shenzhen Innovation Immunotechnology Co., Ltd. (“SIIT”) to establish a tri-party collaboration with next-generation therapies derived from induced pluripotent stem cells (“iPSC”).
Ragnarok M: Eternal Love 2 (Chinese Title 仙境传说:守护永恒的爱2) Received an ISBN Code from Chinese Government
Seoul, South Korea, July 28, 2026 (GLOBE NEWSWIRE) — GRAVITY Co., Ltd. (NasdaqGM: GRVY) (“Gravity” or “Company”), a developer and publisher of online and mobile games, announced that Ragnarok M: Eternal Love 2 (Chinese Title 仙境传说:守护永恒的爱2), an MMORPG Mobile and PC game, received an ISBN code from Chinese government on July 23, 2026.
Trump Turns Up Heat on RFK Jr. Over Vaccines, Warms to Zelensky
From Cracker Barrel to Boeing, Companies Are Turning to Retired CEOs
Hexamethylenediamine Market Size to Surpass USD 18.59 Billion by 2035 on Strong Nylon 6,6 Demand | SNS Insider
U.S. Market to Reach USD 2.93 Billion and Europe USD 4.18 Billion by 2035, Driven by Automotive and Industrial Growth
New Anglia University Examines Why More Students Are Considering Graduate-Entry Routes Into Medicine
Le propriétaire de McVitie’s fixe pour 2030 l’objectif de doubler les ventes de produits présentant un meilleur équilibre nutritionnel
LONDRES, 28 juill. 2026 (GLOBE NEWSWIRE) — L’entreprise à l’origine de McVitie’s, GODIVA et Ülker s’est engagée à doubler, d’ici 2030, le volume de produits qu’elle commercialise contenant moins de sucre, de sel et de graisses saturées, et davantage de nutriments tels que les fibres et les protéines.
McVitie’s owner sets 2030 target to double sales of products with a better nutritional balance
LONDON, July 28, 2026 (GLOBE NEWSWIRE) — The company behind McVitie’s, GODIVA and Ülker has pledged to double the volume of products it sells with lower levels of sugar, salt and saturated fat, and higher levels of nutrients such as fibre and protein, by 2030.
McVitie’s 母公司设定 2030 年目标:营养结构更优产品的销量翻番
伦敦, July 28, 2026 (GLOBE NEWSWIRE) — McVitie’s、GODIVA 和 Ülker 的母公司承诺,到 2030 年将其低糖、低盐、低饱和脂肪且富含纤维、蛋白质等营养素的产品销量翻倍。
Eigenaar van McVitie’s stelt doel voor 2030: verdubbeling van de verkoop van producten met een betere voedingsbalans
LONDEN, July 28, 2026 (GLOBE NEWSWIRE) — Het bedrijf achter McVitie’s, GODIVA en Ülker heeft toegezegd om tegen 2030 het volume van de producten die het verkoopt met lagere gehaltes aan suiker, zout en verzadigde vetten, en hogere gehaltes aan voedingsstoffen zoals vezels en eiwitten, te verdubbelen.
McVitie’s की पैरेंट कंपनी का 2030 तक बेहतर न्यूट्रिशन वाले प्रोडक्ट्स की सेल दोगुनी करने का लक्ष्य
लंदन, July 28, 2026 (GLOBE NEWSWIRE) — McVitie’s, GODIVA और Ülker की मालिकाना कंपनी ने 2030 तक अपने उन प्रोडक्ट्स की सेल दोगुनी करने का संकल्प लिया है, जिनमें चीनी, नमक और सैचुरेटेड फैट की मात्रा कम हो और फाइबर व प्रोटीन जैसे पोषक तत्व ज्यादा हों।
Univar Solutions Acquires Interpur Chemicals, Expanding Access to Polyurethanes and Powder Coatings in EMEA
Promatix Biosciences Awarded Innovate UK Biomedical Catalyst Grant to Advance First-in-Class EGFR × EphA2 Cis-Bispecific ADC
KIDZ AI Issues Shareholder Letter Addressing Disconnect Between Current Share Price and Fundamentals
New York, USA, July 28, 2026 (GLOBE NEWSWIRE) — Net Cash of $13.7 Million – Approximately 3x Market Capitalization; Share Repurchases Underway, with Intent to Accelerate and Expand the Program to $3.0 Million; GPU Compute Revenue Expected to Begin in Q4 2026